You are here

Share:

2020 Technology Showcase

 

Virtual Event, September 9, 2020

Thank you for attending the 2020 Technology Showcase on September 9th. The 4th annual event highlighted technologies being developed at the NCI and the Frederick National Laboratory for Cancer Research (FNL) to encourage technology licensing and collaborations, startup company formation and the translation of NCI discoveries into solutions to benefit patients. If you are interested in learning more about the featured technologies and would like for someone to follow-up with you, please contact us at ncitechtransfer@mail.nih.gov.

OVERVIEW:

  • Free, half-day virtual event
  • Hear from NCI and FNL inventors about technologies primed for technology commercialization and/or collaboration; great opportunity for companies of all sizes including startups and biotech stakeholders
  • Panel sessions focused on technology commercialization
  • Virtual poster session highlighting NCI technologies available for collaborative development and/or licensing presented by the NCI Technology Transfer Ambassadors Program

Date and Time

Wednesday, September 9, 2020
11:45 AM - 5:30 PM, EST U.S.

LinkedIn Event:
Join our concurrent LinkedIn event to encourage engagement and networking


Agenda:

11:45 AM - WebEx event opens

Welcome & Keynote Presenters

Noon - 12:30 PM

Kelly Schulz, Secretary, Maryland Department of Commerce

Howard Bland, Sr. Director Supply Chain, Kite, a Gilead Company


Technology Session 1

12:30 - 1:25 PM

Moderator: Michael Salgaller, Ph.D., TTC, Invention Development and Marketing Unit Supervisor

Stephan Stern, Ph.D., DABT, Laboratory Co-Director, Director of Research and Development, Nanotechnology Characterization Laboratory - "Polymeric Delivery Platform for Therapeutics" E-097-2017
Udo Rudloff, M.D., Ph.D., Investigator, NCI CCR Pediatric Oncology Branch - "Use and Preparation of CD206 Small Molecule Modulators as Therapeutics for CD206-Expressing Cancers" (E-105-2019)
Genoveffa Franchini, M.D., Senior Investigator, NCI CCR, Vaccine Branch - "Preventing HIV Using a Novel Recombinant gp120 Vaccine Modified with a V1-region Deletion" (E-160-2018)
Presented by: Herui Wang, Ph.D., NCI CCR, Neuro-Oncology Branch
Inventor: Zhengping Zhuang, M.D., Ph.D., Senior Investigator, NCI CCR, Neuro-Oncology Branch - "Use of the TP5 Peptide for the Treatment of Cancer" (E-007-2019)
Javed Khan, M.D., Deputy Chief, NCI CCR, Genetics Branch - "Fibroblast Growth Factor Receptor 4 (FGFR4) Monoclonal Antibodies and Methods of Their Use" (E-264-2015)
*Order of presentations subject to change
If you are interested in learning more about these technologies and would like for someone to follow-up with you, please contact us at ncitechtransfer@mail.nih.gov.

Panel Session 1

1:30 - 2:25 PM
The following panels will be offered concurrently. Attendee selects one. Time is subject to change.

Panel 1: How to Attract Investors and Funding for Your Company

(to attend this session, attendees stay connected to the primary WebEx Event link)

Moderator: Elizabeth Cho-Fertikh, Ph.D. Co-Founder, MEDA Angels, Founder, ECF Biosolutions

Panel 2: Partnering with the NCI and FNL to Advance Innovation to Benefit your Pipeline and Your Bottom-line

(to attend this session, attendees connected to a separate WebEx Event link

Moderator: Vladimir Popov, Ph.D., Director, FNL Partnership Development Office

  • Kathleen Carroll, Ph.D., Associate Director, NCI TTC
  • Serguei Kozlov, Ph.D., M.B.A., Team Leader, NCI CCR, Center for Advanced Preclinical Research: Preclinical Technology and Optimization
  • Maurice T. Hampton, M.S., M.B.A, Executive Chairman and CEO, Telesis Therapeutics, LLC

Technology Transfer Ambassadors Program (TTAP) Virtual Poster Sessions

2:30 - 3:25 PM
Posters prepared in partnership with NCI's TTAP will highlight technologies available for licensing and/or commercialization. The following Poster Sessions will be offered concurrently. Attendee selects one.

Poster Group 1

(to attend this session, attendees stayed connected to the primary WebEx Event link)

Moderator: Laura Prestia, Ph.D., TTC, Communications and Strategic Initiatives Manager, TTAP Program Lead

Presented by: Xiaoli Weng, Ph.D., TTC Fellow
Inventor: Stavroula Mili, Ph.D. , NCI CCR, Laboratory of Cellular and Molecular Biology, "Antisense oligos that block cancer cell migration and invasion" (E-041-2020)
VIEW ONE-MINUTE TECHNOLOGY PITCH
Presented by: Cindo Nicholson, Ph.D., TTAP Ambassador
Inventor: Liyanage Perera Ph.D., NCI, CCR, Lymphoid Malignancies Branch, "Chimeric Antigen Receptor (CAR) that Targets Chemokine Receptor CCR4 and its Use in Treating Cancer" (E-258-2016)
VIEW ONE-MINUTE TECHNOLOGY PITCH
Presented by: Mukta Nag, Ph.D., TTAP Senior Ambassador
Inventor: Joel Schneider, Ph.D., NCI, CCR, Chemical Biology Laboratory, "Peptide Hydrogels for Rate-Controlled Delivery of Therapeutics" E-188-2017
VIEW ONE-MINUTE TECHNOLOGY PITCH
Presented by: Jonathan Motley, Ph.D., TTC Fellow
Inventor: Mitchell Ho, Ph.D. NCI, CCR, Laboratory of Molecular Biology, "High Affinity Nanobodies Targeting B7-H3 (CD276) for Treating Multiple Solid Tumors" E-185-2019
VIEW ONE-MINUTE PITCH
Presented by: Weiwei Dai, Ph.D., *Johns Hopkins University Student
Inventor: Stuart Le Grice, Ph.D., NCI, CCR, Basic Research Laboratory "(lncRNA) as Anticancer Agents" (E-060-2018)
VIEW ONE-MINUTE PITCH
Presented by: Eric Ho, Ph.D., Transition to Industry (T2I) fellow and co-inventor
Inventor: David FitzGerald, Ph.D. NCI, CCR, Laboratory of Molecular Biology "EGFRvIII Antibodies for the Treatment of Human Cancer" (E-103-2019)
VIEW ONE-MINUTE PITCH
*Select posters were developed through the TTAP partnership with the Johns Hopkins University
If you are interested in learning more about these technologies and would like for someone to follow-up with you, please contact us at ncitechtransfer@mail.nih.gov.

Poster Group 2

(to attend this session, attendees connected to a separate WebEx Event)

Moderator: Abritee Dhal, Ph.D., TTC Technology Transfer Manager, TTAP Team Lead

Presented by: Albert Burgess-Hull, Ph.D., TTAP Ambassador
Inventor: Melvin DePamphilis, Ph.D., Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH Distinguished Investigator, "Combined PIKFYVE and p38 MAP Kinase Inhibition for Treating Cancer" (E-138-2019)
VIEW ONE-MINUTE PITCH
Presented by: Berna Uygur, Ph.D., TTC Fellow
Inventor: Xin Wei Wang, Ph.D. NCI, CCR, Laboratory of Human Carcinogenesis, "A Viral Exposure Signature to Define and Detect Early Onset Hepatocellular Carcinoma" (E-174-2019)
VIEW ONE-MINUTE PITCH
Presented by: Diptadip Dattaroy, Ph.D., TTAP Ambassador/TTC Fellow  
Inventor: Stephen Hewitt, M.D., Ph.D., NCI, CCR, Laboratory of Pathology, "Ratio Based Biomarkers for the Prediction of Cancer Survival" (E-025-2009)
VIEW ONE-MINUTE PITCH
Presented by Fei Zhao, Ph.D., TTAP Ambassador
Inventor: Allan Weissman, M.D. NCI, CCR, Laboratory of Protein Dynamics and Signaling, "Peptides that Modulate Endoplasmic Reticulum (ER)-Associated Degradation by Sequestering" (E-122-2018)
VIEW ONE-MINUTE PITCH

Presented by Hiba Alsaffar, Ph.D., TTC Fellow
Inventor: Stanislav Tamarev, Ph.D.  National Eye Institute, Retinal Ganglion Cell Biology, "Bone Marrow Mesenchymal Stem Cell (BMSC)-Derived Exosomes for the Treatment of Glaucoma" (E-044-2018) 
VIEW ONE-MINUTE PITCH

If you are interested in learning more about these technologies and would like for someone to follow-up with you, please contact us at ncitechtransfer@mail.nih.gov.

Technology Session 2

3:30 - 4:20 PM

Moderator: Maggie Scully, Ph.D., Senior Strategic Business Development Analyst, FNL Partnership Development Office

Brad St. Croix, Ph.D., Senior Associate Scientist, NCI CCR, Mouse Cancer Genetics Program - "Fully Human Antibodies and Antibody Drug Conjugates Targeting CD276 (B7-H3) for the Treatment of Cancer" (E-250-2014)
Stavroula Mili, Ph.D., NCI CCR, Laboratory of Cellular and Molecular Biology - "Antisense Oligonucleotides against Cancer Cell Migration and Invasion" (E-041-2020)
Uma Mudunuri M.S., Advanced Biomedical Computational Science, FNL – "Analytics and Visualization through interactive Data (AViD) Dashboards" 
Benjamin Madej, Ph.D., Data Scientist, Accelerating Therapeutics for Opportunities in Medicine (ATOM), FNL – “AMPL: A Data-Driven Modeling Pipeline for Drug Discovery”
*Order of presentations subject to change
If you are interested in learning more about these technologies and would like for someone to follow-up with you, please contact us at ncitechtransfer@mail.nih.gov.

Panel Session 2:

4:25 – 5:15 PM
The following panels will be offered concurrently. Attendee selects one.

Panel 3: Government and Non-Profit Funding and Resources for Startups

(to attend this session, attendees stayed connected to the primary WebEx Event link)

Moderator: Heather Gramm, CEcD, Senior Director, Strategic Industries and Entrepreneurship, Maryland Department of Commerce

  • Christie Canaria, Ph.D., Program Director, NCI SBIR
  • Javeed Froozan, VP Research and Business Development and Strategic Alliances, Leukemia and Lymphoma Society
  • Ulyana V. Desiderio, Ph.D., Director, BioHealth and Life Sciences at Maryland Department of Commerce
  • John Bittman, Interagency Policy Specialist, Technology Partnerships Office, National Institute of Standards and Technology
Panel 4: Leveraging Incubators and Accelerators to Speed Tech Licensing and Commercialization

(to attend this session, attendees connected to a separate WebEx event.

Moderator: Kathie Callahan Brady, CEO, Frederick Innovative Technology Center Inc. (FITCI)

  • Xiaonao Liu, Ph.D., CEO, Nanobiofab
  • Sue E. Carr RPh., President and Founder, CarrTech LLC
  • Jon Rowley, Founder & Chief Product Office, RoosterBio, Inc.

 

 

 

Updated
Thursday, September 10, 2020